After Omicron, some scientists foresee ‘a period of quiet’.
After Omicron, some scientists foresee ‘a period of quiet’ – Science
The post After Omicron, some scientists foresee ‘a period of quiet’. appeared first on Links Medicus.
Perspective | Where do we stand with Omicron? The data, the math, the patterns, and the exit.
Where do we stand with Omicron? – by Dr. Eric Topol Commentary on Twitter Where do we stand with Omicron?I've summarized the new data, math, patterns, and potential exit ramphttps://t.co/SyCmCzkBQX @SubstackInc — Eric Topol (@EricTopol) January 22, 2022
The post Perspective | Where do we stand with Omicron? The data, the math, the patterns, and the exit. appeared first on Links Medicus.
Clinical characteristics and outcomes of patients with COVID-19–Associated Acute Respiratory Distress Syndrome who underwent lung transplant.
Clinical Characteristics and Outcomes of Patients With COVID-19–Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant – JAMA Related: Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.
The post Clinical characteristics and outcomes of patients with COVID-19–Associated Acute Respiratory Distress Syndrome who underwent lung transplant. appeared first on Links Medicus.
RCT: Hyperimmune immunoglobulin did not improve outcomes in hospitalized patients with COVID-19.
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial – The Lancet Commentaries: High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19 – The Lancet Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19 – NIH News Releases
The post RCT: Hyperimmune immunoglobulin did not improve outcomes in hospitalized patients with COVID-19. appeared first on Links Medicus.
Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.
Lung Transplantation for Covid-19–Related Respiratory Failure in the United States – New England Journal of Medicine Commentaries: New data on COVID-19 lung transplants – Cedars-Sinai Medical Center ~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure – HealthDay
The post Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%. appeared first on Links Medicus.
Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant – New England Journal of Medicine Commentary: Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds – University of Wisconsin-Madison Commentary on Twitter Investigators assessed the in vitro activities of seven monoclonal antibodies & three antiviral drugs against […]
The post Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective. appeared first on Links Medicus.
Comprehensive review of chest tube management.
Comprehensive Review of Chest Tube Management – JAMA Surgery (free for a limited period)
The post Comprehensive review of chest tube management. appeared first on Links Medicus.
Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold.
Oral antihistamine‐decongestant‐analgesic combinations for the common cold – Cochrane Library Commentary: Oral antihistamine-decongestant-analgesic combinations for the common cold – Cochrane Library
The post Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold. appeared first on Links Medicus.
A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole.
Trimethoprim-Sulfamethoxazole versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 U.S. Hospitals – Open Forum Infectious Diseases Commentary on Twitter A new study in OFID suggests that mortality outcomes are similar comparing levofloxacin and TMP/SMX treatment of S. maltophilia lower respiratory tract and bloodstream infections. ?:https://t.co/80QDy3DTU9 #IDSAJournals @PaulSaxMD @DrJLi @Keith_S_Kaye […]
The post A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole. appeared first on Links Medicus.
RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults.
Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults – NEJM Evidence Related: A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention
The post RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults. appeared first on Links Medicus.